4 ms·
that 62% number is for symptomatic cases, I think it was around 50% for asymptomatic cases - the different efficacy-rates are fairly comparable
by BillyTheKing 6y ago
that 62% number is for symptomatic cases, I think it was around 50% for asymptomatic cases - the different efficacy-rates are fairly comparable
- emn13 6y agoThat is a good point, I'd forgotten that bit ;-). (ref: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6... vs. e.g. https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 )